| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | disaccharide binding | 6.49e-07 | 7 | 54 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 1.55e-06 | 9 | 54 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 2.06e-05 | 20 | 54 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 7.21e-05 | 30 | 54 | 3 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 7.21e-05 | 30 | 54 | 3 | GO:0097472 | |
| GeneOntologyMolecularFunction | protein kinase regulator activity | 6.65e-04 | 259 | 54 | 5 | GO:0019887 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 7.05e-04 | 149 | 54 | 4 | GO:0030295 | |
| GeneOntologyMolecularFunction | kinase activator activity | 8.98e-04 | 159 | 54 | 4 | GO:0019209 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 1.19e-03 | 19 | 54 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 1.23e-03 | 78 | 54 | 3 | GO:0043539 | |
| GeneOntologyMolecularFunction | kinase regulator activity | 1.38e-03 | 305 | 54 | 5 | GO:0019207 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 6.40e-08 | 4 | 53 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 7.60e-07 | 28 | 53 | 4 | GO:2000561 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 8.89e-07 | 8 | 53 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 1.01e-06 | 30 | 53 | 4 | GO:0035739 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 2.41e-06 | 37 | 53 | 4 | GO:0033081 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 3.67e-06 | 41 | 53 | 4 | GO:2000406 | |
| GeneOntologyBiologicalProcess | positive regulation of mononuclear cell migration | 7.00e-06 | 104 | 53 | 5 | GO:0071677 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 7.13e-06 | 15 | 53 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 7.13e-06 | 15 | 53 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte migration | 7.55e-06 | 49 | 53 | 4 | GO:2000403 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 8.95e-06 | 290 | 53 | 7 | GO:0050870 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell proliferation | 1.04e-05 | 53 | 53 | 4 | GO:0046640 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 1.04e-05 | 53 | 53 | 4 | GO:0048247 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 1.06e-05 | 17 | 53 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | T cell differentiation in thymus | 1.10e-05 | 114 | 53 | 5 | GO:0033077 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 1.27e-05 | 18 | 53 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | regulation of T cell migration | 1.29e-05 | 56 | 53 | 4 | GO:2000404 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.47e-05 | 313 | 53 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 1.50e-05 | 579 | 53 | 9 | GO:0045785 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 1.51e-05 | 19 | 53 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 1.51e-05 | 19 | 53 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell proliferation | 1.59e-05 | 59 | 53 | 4 | GO:0046633 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 1.59e-05 | 317 | 53 | 7 | GO:1903039 | |
| GeneOntologyBiologicalProcess | positive regulation of cytokine production | LGALS9C LGALS9B ABCC8 BTNL2 SERPINE1 CARD11 ADAM8 PNP LGALS9 | 1.65e-05 | 586 | 53 | 9 | GO:0001819 |
| GeneOntologyBiologicalProcess | regulation of cell development | LGALS9C ZBTB7A LGALS9B ABCC8 LRP2 KDR CARD11 ADAM8 NOS1 PNP LGALS9 SYNGAP1 | 1.66e-05 | 1095 | 53 | 12 | GO:0060284 |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 1.77e-05 | 20 | 53 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | LGALS9C LGALS9B RELL2 BTNL2 SERPINE1 KDR CARD11 ADAM8 PNP EPHA5 LGALS9 | 1.92e-05 | 927 | 53 | 11 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 2.06e-05 | 21 | 53 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 2.42e-05 | 226 | 53 | 6 | GO:0045580 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor superfamily cytokine production | 2.67e-05 | 137 | 53 | 5 | GO:1903557 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell activation | 3.06e-05 | 141 | 53 | 5 | GO:0046634 | |
| GeneOntologyBiologicalProcess | regulation of T cell proliferation | 3.08e-05 | 236 | 53 | 6 | GO:0042129 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 3.39e-05 | 144 | 53 | 5 | GO:0045582 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 3.99e-05 | 26 | 53 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte migration | 4.58e-05 | 77 | 53 | 4 | GO:2000401 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 5.50e-05 | 385 | 53 | 7 | GO:0051251 | |
| GeneOntologyBiologicalProcess | T cell migration | 5.58e-05 | 81 | 53 | 4 | GO:0072678 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 5.58e-05 | 81 | 53 | 4 | GO:0043030 | |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell migration | 5.61e-05 | 160 | 53 | 5 | GO:0071675 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 5.87e-05 | 389 | 53 | 7 | GO:0022409 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 5.95e-05 | 162 | 53 | 5 | GO:0045621 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 6.01e-05 | 266 | 53 | 6 | GO:0045619 | |
| GeneOntologyBiologicalProcess | receptor clustering | 6.14e-05 | 83 | 53 | 4 | GO:0043113 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 6.84e-05 | 31 | 53 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 6.84e-05 | 31 | 53 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 7.54e-05 | 32 | 53 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | LGALS9C CDH22 HMCN2 CELSR3 LGALS9B BTNL2 MYPN CARD11 ADAM8 PNP LGALS9 | 7.54e-05 | 1077 | 53 | 11 | GO:0098609 |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 8.28e-05 | 33 | 53 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | T cell proliferation | 9.31e-05 | 288 | 53 | 6 | GO:0042098 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte migration | 9.53e-05 | 179 | 53 | 5 | GO:0002687 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 9.92e-05 | 423 | 53 | 7 | GO:0002696 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 1.08e-04 | 429 | 53 | 7 | GO:1902105 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte proliferation | 1.19e-04 | 301 | 53 | 6 | GO:0050670 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 1.27e-04 | 38 | 53 | 3 | GO:0001779 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell activation | 1.27e-04 | 100 | 53 | 4 | GO:2000514 | |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell proliferation | 1.30e-04 | 306 | 53 | 6 | GO:0032944 | |
| GeneOntologyBiologicalProcess | export from cell | LGALS9C CDK16 SLC24A4 LGALS9B ABCC8 MYO19 EXOC7 ADAM8 NOS1 EPHA5 LGALS9 | 1.38e-04 | 1153 | 53 | 11 | GO:0140352 |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 1.40e-04 | 447 | 53 | 7 | GO:1903037 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 1.44e-04 | 449 | 53 | 7 | GO:0050867 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.48e-04 | 40 | 53 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell activation | 1.48e-04 | 40 | 53 | 3 | GO:2000515 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.59e-04 | 41 | 53 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 1.62e-04 | 458 | 53 | 7 | GO:0050863 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 1.71e-04 | 42 | 53 | 3 | GO:0002323 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-2 production | 1.71e-04 | 42 | 53 | 3 | GO:0032743 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 1.71e-04 | 42 | 53 | 3 | GO:0043032 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 1.84e-04 | 43 | 53 | 3 | GO:0060391 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNG7 SLC9A3 SLC24A4 ABCC8 SERPINE1 LRP2 FGF11 GRIN3A NOS1 CDK2 | 2.00e-04 | 1000 | 53 | 10 | GO:0030001 |
| GeneOntologyBiologicalProcess | regulation of leukocyte proliferation | 2.02e-04 | 332 | 53 | 6 | GO:0070663 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 2.10e-04 | 114 | 53 | 4 | GO:0045824 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 2.11e-04 | 45 | 53 | 3 | GO:0045920 | |
| GeneOntologyBiologicalProcess | regulation of cytokine production | LGALS9C IGF2BP2 LGALS9B ABCC8 BTNL2 SERPINE1 CARD11 ADAM8 PNP LGALS9 | 2.16e-04 | 1010 | 53 | 10 | GO:0001817 |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.17e-04 | 115 | 53 | 4 | GO:0090100 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | 2.20e-04 | 214 | 53 | 5 | GO:1903531 | |
| GeneOntologyBiologicalProcess | lymphocyte migration | 2.25e-04 | 116 | 53 | 4 | GO:0072676 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 2.25e-04 | 46 | 53 | 3 | GO:0051353 | |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | 2.33e-04 | 486 | 53 | 7 | GO:0007159 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.40e-04 | 47 | 53 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 2.40e-04 | 47 | 53 | 3 | GO:2000316 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-10 production | 2.55e-04 | 48 | 53 | 3 | GO:0032733 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.56e-04 | 347 | 53 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | regulation of regulatory T cell differentiation | 2.71e-04 | 49 | 53 | 3 | GO:0045589 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell activation | 2.88e-04 | 227 | 53 | 5 | GO:0046631 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 2.90e-04 | 124 | 53 | 4 | GO:0001910 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell proliferation | 2.99e-04 | 125 | 53 | 4 | GO:0042102 | |
| GeneOntologyBiologicalProcess | negative regulation of type II interferon production | 3.06e-04 | 51 | 53 | 3 | GO:0032689 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell activation | 3.24e-04 | 52 | 53 | 3 | GO:0046636 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 3.24e-04 | 52 | 53 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | cell chemotaxis | 3.26e-04 | 363 | 53 | 6 | GO:0060326 | |
| GeneOntologyBiologicalProcess | chemotaxis | 3.39e-04 | 517 | 53 | 7 | GO:0006935 | |
| GeneOntologyBiologicalProcess | regulation of tumor necrosis factor superfamily cytokine production | 3.45e-04 | 236 | 53 | 5 | GO:1903555 | |
| GeneOntologyBiologicalProcess | taxis | 3.47e-04 | 519 | 53 | 7 | GO:0042330 | |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 3.62e-04 | 54 | 53 | 3 | GO:0045066 | |
| GeneOntologyBiologicalProcess | regulation of T cell apoptotic process | 3.62e-04 | 54 | 53 | 3 | GO:0070232 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion | 3.65e-04 | 239 | 53 | 5 | GO:0051048 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | 3.67e-04 | 694 | 53 | 8 | GO:0002694 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor production | 3.79e-04 | 133 | 53 | 4 | GO:0032760 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 3.87e-04 | 242 | 53 | 5 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 3.87e-04 | 242 | 53 | 5 | GO:1903708 | |
| GeneOntologyBiologicalProcess | regulation of chemotaxis | 3.87e-04 | 242 | 53 | 5 | GO:0050920 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.68e-04 | 658 | 54 | 8 | GO:0030312 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.09e-04 | 530 | 54 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 5.27e-04 | 61 | 54 | 3 | GO:0000307 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 7.23e-04 | 157 | 54 | 4 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 9.73e-04 | 170 | 54 | 4 | GO:1902911 | |
| MousePheno | increased T-helper cell number | 9.30e-07 | 56 | 45 | 5 | MP:0013763 | |
| MousePheno | abnormal T-helper cell number | 1.62e-06 | 114 | 45 | 6 | MP:0013761 | |
| MousePheno | decreased regulatory T cell number | 1.82e-06 | 64 | 45 | 5 | MP:0004974 | |
| MousePheno | abnormal effector T cell number | 3.49e-06 | 203 | 45 | 7 | MP:0013762 | |
| MousePheno | lymph node hyperplasia | 3.58e-06 | 33 | 45 | 4 | MP:0008102 | |
| MousePheno | abnormal T-helper cell morphology | 7.66e-06 | 149 | 45 | 6 | MP:0013760 | |
| MousePheno | abnormal CD4-positive helper T cell morphology | 1.65e-05 | 100 | 45 | 5 | MP:0010183 | |
| MousePheno | enhanced humoral immune response | 2.05e-05 | 17 | 45 | 3 | MP:0020155 | |
| MousePheno | increased T-helper 1 cell number | 2.91e-05 | 19 | 45 | 3 | MP:0008086 | |
| MousePheno | abnormal regulatory T cell number | 3.24e-05 | 115 | 45 | 5 | MP:0004972 | |
| MousePheno | abnormal regulatory T cell morphology | 3.52e-05 | 117 | 45 | 5 | MP:0004941 | |
| MousePheno | increased spleen germinal center size | 5.28e-05 | 23 | 45 | 3 | MP:0008483 | |
| MousePheno | abnormal lymph node germinal center morphology | 5.28e-05 | 23 | 45 | 3 | MP:0008522 | |
| MousePheno | abnormal T-helper 1 cell number | 6.02e-05 | 24 | 45 | 3 | MP:0008085 | |
| MousePheno | abnormal lymph node secondary follicle morphology | 6.82e-05 | 25 | 45 | 3 | MP:0002346 | |
| MousePheno | increased B cell proliferation | 9.64e-05 | 75 | 45 | 4 | MP:0005154 | |
| MousePheno | abnormal gamma-delta T cell morphology | 1.12e-04 | 78 | 45 | 4 | MP:0008343 | |
| MousePheno | increased CD4-positive, alpha-beta T cell number | 1.14e-04 | 241 | 45 | 6 | MP:0008074 | |
| MousePheno | abnormal B cell proliferation | 1.22e-04 | 152 | 45 | 5 | MP:0005153 | |
| MousePheno | abnormal renal water reabsorption | 1.51e-04 | 6 | 45 | 2 | MP:0010108 | |
| MousePheno | spleen hyperplasia | 1.57e-04 | 85 | 45 | 4 | MP:0000693 | |
| MousePheno | thymus hyperplasia | 1.74e-04 | 34 | 45 | 3 | MP:0000708 | |
| MousePheno | abnormal B cell activation | 1.85e-04 | 166 | 45 | 5 | MP:0008217 | |
| MousePheno | increased susceptibility to induced arthritis | 2.07e-04 | 36 | 45 | 3 | MP:0003724 | |
| MousePheno | decreased KLRG1-positive NK cell number | 2.80e-04 | 8 | 45 | 2 | MP:0012768 | |
| MousePheno | enlarged thymus | 3.24e-04 | 292 | 45 | 6 | MP:0000709 | |
| MousePheno | abnormal renal water transport | 3.60e-04 | 9 | 45 | 2 | MP:0011443 | |
| MousePheno | increased NK T cell number | 3.76e-04 | 44 | 45 | 3 | MP:0008039 | |
| MousePheno | abnormal lymph node B cell domain morphology | 3.76e-04 | 44 | 45 | 3 | MP:0002344 | |
| MousePheno | abnormal thymus size | 3.85e-04 | 564 | 45 | 8 | MP:0002364 | |
| MousePheno | abnormal thymus morphology | 3.92e-04 | 717 | 45 | 9 | MP:0000703 | |
| MousePheno | autoimmune arthritis | 3.93e-04 | 108 | 45 | 4 | MP:0002993 | |
| MousePheno | abnormal renal water homeostasis | 4.49e-04 | 10 | 45 | 2 | MP:0011444 | |
| MousePheno | increased alpha-beta T cell number | 4.53e-04 | 311 | 45 | 6 | MP:0012764 | |
| MousePheno | abnormal T-helper 1 cell morphology | 4.87e-04 | 48 | 45 | 3 | MP:0002433 | |
| MousePheno | abnormal lymph node cortex morphology | 5.50e-04 | 50 | 45 | 3 | MP:0002343 | |
| MousePheno | abnormal lymphocyte morphology | LGALS9C ZBTB7A LGALS9B BTNL2 FAM3A GMDS CARD11 ADGRF5 SRPX PKHD1L1 TRAPPC9 PNP LGALS9 | 5.76e-04 | 1483 | 45 | 13 | MP:0002619 |
| MousePheno | increased T cell number | 7.41e-04 | 475 | 45 | 7 | MP:0005015 | |
| MousePheno | abnormal endocrine gland morphology | LGALS9C SLC24A4 LGALS9B ABCC8 LRP2 CARD11 SRPX TRAPPC9 SPRYD4 PNP LGALS9 | 7.94e-04 | 1144 | 45 | 11 | MP:0013560 |
| MousePheno | joint inflammation | 8.15e-04 | 131 | 45 | 4 | MP:0002933 | |
| MousePheno | abnormal KLRG1-positive NK cell number | 9.00e-04 | 14 | 45 | 2 | MP:0012766 | |
| MousePheno | decreased effector memory CD8-positive, alpha-beta T cell number | 9.00e-04 | 14 | 45 | 2 | MP:0010851 | |
| MousePheno | decreased lymphocyte cell number | LGALS9C ZBTB7A LGALS9B GMDS CARD11 ADGRF5 PKHD1L1 TRAPPC9 PNP LGALS9 | 1.00e-03 | 992 | 45 | 10 | MP:0005016 |
| MousePheno | abnormal joint physiology | 1.19e-03 | 145 | 45 | 4 | MP:0031169 | |
| MousePheno | abnormal CD8-positive, naive alpha-beta T cell number | 1.29e-03 | 67 | 45 | 3 | MP:0013434 | |
| MousePheno | decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number | 1.34e-03 | 17 | 45 | 2 | MP:0010169 | |
| MousePheno | abnormal phagocyte morphology | LGALS9C LGALS9B FAM3A GMDS ADGRF5 ADAM8 PKHD1L1 NOS1 TRAPPC9 LGALS9 | 1.37e-03 | 1033 | 45 | 10 | MP:0008251 |
| MousePheno | abnormal gamma-delta T cell number | 1.41e-03 | 69 | 45 | 3 | MP:0008345 | |
| MousePheno | abnormal effector memory CD8-positive, alpha-beta T cell number | 1.41e-03 | 69 | 45 | 3 | MP:0010849 | |
| MousePheno | abnormal CD4-positive, alpha-beta T cell number | 1.49e-03 | 391 | 45 | 6 | MP:0008073 | |
| Domain | Gal-bind_lectin | 9.58e-06 | 15 | 53 | 3 | PF00337 | |
| Domain | Gal-bind_lectin | 9.58e-06 | 15 | 53 | 3 | SM00908 | |
| Domain | GALECTIN | 9.58e-06 | 15 | 53 | 3 | PS51304 | |
| Domain | Galectin_CRD | 9.58e-06 | 15 | 53 | 3 | IPR001079 | |
| Domain | GLECT | 9.58e-06 | 15 | 53 | 3 | SM00276 | |
| Domain | Ig-like_fold | 1.49e-04 | 706 | 53 | 9 | IPR013783 | |
| Domain | - | 1.52e-04 | 95 | 53 | 4 | 2.60.120.200 | |
| Domain | ConA-like_dom | 3.84e-04 | 219 | 53 | 5 | IPR013320 | |
| Domain | Ig-like_dom | 5.20e-04 | 503 | 53 | 7 | IPR007110 | |
| Domain | - | 5.22e-04 | 663 | 53 | 8 | 2.60.40.10 | |
| Domain | IGc2 | 5.30e-04 | 235 | 53 | 5 | SM00408 | |
| Domain | Ig_sub2 | 5.30e-04 | 235 | 53 | 5 | IPR003598 | |
| Domain | EGF-like_CS | 8.51e-04 | 261 | 53 | 5 | IPR013032 | |
| Domain | EGF_2 | 9.11e-04 | 265 | 53 | 5 | PS01186 | |
| Domain | IG | 1.19e-03 | 421 | 53 | 6 | SM00409 | |
| Domain | Ig_sub | 1.19e-03 | 421 | 53 | 6 | IPR003599 | |
| Domain | Ig_I-set | 2.06e-03 | 190 | 53 | 4 | IPR013098 | |
| Domain | I-set | 2.06e-03 | 190 | 53 | 4 | PF07679 | |
| Domain | IG_LIKE | 2.58e-03 | 491 | 53 | 6 | PS50835 | |
| Domain | ASX_HYDROXYL | 2.87e-03 | 100 | 53 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.39e-03 | 106 | 53 | 3 | IPR000152 | |
| Domain | GPS | 4.18e-03 | 34 | 53 | 2 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 4.18e-03 | 34 | 53 | 2 | IPR017983 | |
| Domain | Protein_kinase_ATP_BS | 4.33e-03 | 379 | 53 | 5 | IPR017441 | |
| Domain | EGF_3 | 4.42e-03 | 235 | 53 | 4 | PS50026 | |
| Domain | GPS | 4.43e-03 | 35 | 53 | 2 | PF01825 | |
| Domain | GPS | 4.68e-03 | 36 | 53 | 2 | PS50221 | |
| Domain | GPS | 4.94e-03 | 37 | 53 | 2 | IPR000203 | |
| Domain | EGF_CA | 5.02e-03 | 122 | 53 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.25e-03 | 124 | 53 | 3 | IPR001881 | |
| Domain | EGF-like_dom | 5.41e-03 | 249 | 53 | 4 | IPR000742 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 5.75e-03 | 40 | 53 | 2 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 5.75e-03 | 40 | 53 | 2 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 5.75e-03 | 40 | 53 | 2 | PS50227 | |
| Domain | EGF_1 | 5.88e-03 | 255 | 53 | 4 | PS00022 | |
| Domain | ABC_transporter_CS | 6.33e-03 | 42 | 53 | 2 | IPR017871 | |
| Domain | ER_TARGET | 7.87e-03 | 47 | 53 | 2 | PS00014 | |
| Domain | ABC_tran | 8.20e-03 | 48 | 53 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 8.20e-03 | 48 | 53 | 2 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 8.53e-03 | 49 | 53 | 2 | PS00211 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 8.87e-03 | 50 | 53 | 2 | PS00650 | |
| Domain | 7tm_2 | 8.87e-03 | 50 | 53 | 2 | PF00002 | |
| Domain | ABC_transporter-like | 8.87e-03 | 50 | 53 | 2 | IPR003439 | |
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 3.54e-09 | 3 | 54 | 3 | 29458010 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 19776007 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 26582205 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 9153289 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 33316546 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 18974023 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 9038233 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 3.54e-09 | 3 | 54 | 3 | 29651447 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 28704475 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 21146220 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 3.54e-09 | 3 | 54 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 3.54e-09 | 3 | 54 | 3 | 22341088 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 3.54e-09 | 3 | 54 | 3 | 28990062 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 32380082 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 23667648 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 18579572 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 28877989 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 19800850 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 38987795 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 16990264 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 18005988 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 23585851 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 3.54e-09 | 3 | 54 | 3 | 29433546 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 37105392 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 36479526 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 3.54e-09 | 3 | 54 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 3.54e-09 | 3 | 54 | 3 | 33923930 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 3.54e-09 | 3 | 54 | 3 | 25898318 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 31937306 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 21426359 | ||
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 3.54e-09 | 3 | 54 | 3 | 31969388 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 18282810 | ||
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 3.54e-09 | 3 | 54 | 3 | 35241678 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 24083426 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 37279535 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 3.54e-09 | 3 | 54 | 3 | 25931247 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 22627368 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 33153471 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 22052881 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 17560833 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 3.54e-09 | 3 | 54 | 3 | 23408620 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 38686388 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 22677125 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 19234217 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 35715604 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 19017954 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 1.41e-08 | 4 | 54 | 3 | 33963043 | |
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 1.41e-08 | 4 | 54 | 3 | 36459823 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 33107565 | ||
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 1.41e-08 | 4 | 54 | 3 | 29611821 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 30763585 | ||
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 1.41e-08 | 4 | 54 | 3 | 33727589 | |
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 1.41e-08 | 4 | 54 | 3 | 19362679 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 25578313 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 29844236 | ||
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 1.41e-08 | 4 | 54 | 3 | 20463811 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 1.41e-08 | 4 | 54 | 3 | 23657851 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 18826117 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 24333756 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 38853593 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 1.41e-08 | 4 | 54 | 3 | 24958847 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 30120235 | ||
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 1.41e-08 | 4 | 54 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 1.41e-08 | 4 | 54 | 3 | 18346632 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 11839756 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 19670381 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 1.41e-08 | 4 | 54 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 1.41e-08 | 4 | 54 | 3 | 34369876 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 33203936 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 1.41e-08 | 4 | 54 | 3 | 22021615 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 29242193 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 28951537 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 3.53e-08 | 5 | 54 | 3 | 34847625 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 22469568 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 25158758 | ||
| Pubmed | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. | 3.53e-08 | 5 | 54 | 3 | 19782405 | |
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 3.53e-08 | 5 | 54 | 3 | 9566950 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 26278059 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 37352334 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 33664349 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 3.53e-08 | 5 | 54 | 3 | 37884694 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 21385853 | ||
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 28394331 | ||
| Pubmed | Tim3 binding to galectin-9 stimulates antimicrobial immunity. | 7.05e-08 | 6 | 54 | 3 | 20937702 | |
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 8674632 | ||
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 23296703 | ||
| Pubmed | 1.20e-07 | 29 | 54 | 4 | 24003143 | ||
| Pubmed | Role of galectin-1 in the developing mouse olfactory system. | 1.23e-07 | 7 | 54 | 3 | 8873770 | |
| Pubmed | 1.97e-07 | 8 | 54 | 3 | 23751344 | ||
| Pubmed | 1.97e-07 | 8 | 54 | 3 | 31661141 | ||
| Pubmed | 1.97e-07 | 8 | 54 | 3 | 36883358 | ||
| Pubmed | 2.95e-07 | 9 | 54 | 3 | 21670307 | ||
| Pubmed | Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. | 2.95e-07 | 9 | 54 | 3 | 25065622 | |
| Interaction | NOS1AP interactions | 5.04e-07 | 113 | 53 | 6 | int:NOS1AP | |
| GeneFamily | Galectins | 5.20e-06 | 15 | 42 | 3 | 629 | |
| GeneFamily | Cyclin dependent kinases | 2.92e-05 | 26 | 42 | 3 | 496 | |
| GeneFamily | Immunoglobulin like domain containing | 8.12e-05 | 193 | 42 | 5 | 594 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.21e-04 | 161 | 42 | 4 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 6.38e-03 | 163 | 42 | 3 | 590 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | 8.71e-06 | 506 | 54 | 8 | M253 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 1.15e-05 | 143 | 54 | 5 | M1935 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 1.15e-05 | 143 | 54 | 5 | MM819 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 5.45e-05 | 100 | 54 | 4 | MM514 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 7.23e-05 | 210 | 54 | 5 | M2010 | |
| Coexpression | DESCARTES_ORGANOGENESIS_GRANULE_NEURONS | 8.34e-05 | 41 | 54 | 3 | MM3647 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 8.44e-05 | 217 | 54 | 5 | MM861 | |
| Coexpression | AFFAR_YY1_TARGETS_UP | 8.44e-05 | 217 | 54 | 5 | MM1156 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 1.38e-06 | 158 | 54 | 5 | 8f66979e92f886d86cecbd26aaa0c5915c049734 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-06 | 163 | 54 | 5 | 63b0badaee3b2d827b1f4524510e3384d8f8fcde | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-06 | 173 | 54 | 5 | e05cddf5bf63cf419343ff229453327519765be8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-06 | 173 | 54 | 5 | 74ad5ed33821b8816c9c8e67c50ee4496ba18e2f | |
| ToppCell | wk_15-18-Epithelial-PNS-SST+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.76e-06 | 182 | 54 | 5 | a7e77aaaddabf78c7784f72b3431703fc5ee4a8c | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.15e-06 | 187 | 54 | 5 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 3.68e-06 | 193 | 54 | 5 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | Endothelial-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.87e-06 | 195 | 54 | 5 | c3a0aa34b672c99cb3a2a4e9218412dbd19da3ca | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-06 | 197 | 54 | 5 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.27e-06 | 199 | 54 | 5 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 157 | 54 | 4 | 3cffedafff31efb5b3259194157b54a768367459 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 157 | 54 | 4 | f87e867a394b0453ebd92c592e80450caf5902cb | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor | 4.24e-05 | 160 | 54 | 4 | 0cfe130606af433b2aa90e0a20b6c44659dd6fd4 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.35e-05 | 161 | 54 | 4 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.45e-05 | 162 | 54 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.78e-05 | 165 | 54 | 4 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.89e-05 | 166 | 54 | 4 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.01e-05 | 167 | 54 | 4 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.13e-05 | 168 | 54 | 4 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | Endothelial-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 5.13e-05 | 168 | 54 | 4 | 4977c3837fbb1f36c89fddd5764e37290ac25ad8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.25e-05 | 169 | 54 | 4 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 5.25e-05 | 169 | 54 | 4 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.49e-05 | 171 | 54 | 4 | 3112d15f2a28cf4a71992db4971d960716dc1264 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.62e-05 | 172 | 54 | 4 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.75e-05 | 173 | 54 | 4 | 3d7c281a1a9f183a5a861d1a9c7b50d216535893 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.75e-05 | 173 | 54 | 4 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 5.75e-05 | 173 | 54 | 4 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.75e-05 | 173 | 54 | 4 | 3aa90578371039f81b7c6fa873ec70f8f2bc7dfa | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 175 | 54 | 4 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 175 | 54 | 4 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 175 | 54 | 4 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 176 | 54 | 4 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 6.14e-05 | 176 | 54 | 4 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.28e-05 | 177 | 54 | 4 | 43dce527392f3b8364bb6a55268ce9d6518d3a29 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.42e-05 | 178 | 54 | 4 | c227da59dc7beb73f84405bf13356bdeb59d9338 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.56e-05 | 179 | 54 | 4 | dfd5b25f2a6a5a8bf4714f1516cb0997de72b06f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.70e-05 | 180 | 54 | 4 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.70e-05 | 180 | 54 | 4 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.70e-05 | 180 | 54 | 4 | 5861b44acfb8fe92c281c8355bf19c059b3dcd64 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 6.85e-05 | 181 | 54 | 4 | 61608123959483ff60f07d8467996853c4371b6a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.85e-05 | 181 | 54 | 4 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.85e-05 | 181 | 54 | 4 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.85e-05 | 181 | 54 | 4 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.85e-05 | 181 | 54 | 4 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.00e-05 | 182 | 54 | 4 | 345d0f9d5ee30434bc2aac17608ccdc9e61c8fa3 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.15e-05 | 183 | 54 | 4 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 7.15e-05 | 183 | 54 | 4 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.30e-05 | 184 | 54 | 4 | a809b0fa52df8a159f60f87eefcef61220af5e34 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.30e-05 | 184 | 54 | 4 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.30e-05 | 184 | 54 | 4 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 7.30e-05 | 184 | 54 | 4 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.45e-05 | 185 | 54 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 7.45e-05 | 185 | 54 | 4 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 7.45e-05 | 185 | 54 | 4 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 7.45e-05 | 185 | 54 | 4 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.61e-05 | 186 | 54 | 4 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.77e-05 | 187 | 54 | 4 | 29b2e2be26a9d72b154760e47acf61cfe2f45fa7 | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.77e-05 | 187 | 54 | 4 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 7.77e-05 | 187 | 54 | 4 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 7.93e-05 | 188 | 54 | 4 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.93e-05 | 188 | 54 | 4 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_bronchial_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.93e-05 | 188 | 54 | 4 | 986aaf31161ec3d1e6c76ee2dd17f44848a21f7e | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-NK-Intermediate_NK|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.93e-05 | 188 | 54 | 4 | a8170e4ce6406af9f5ad5317e6e26efa7bc66411 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.93e-05 | 188 | 54 | 4 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.93e-05 | 188 | 54 | 4 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.10e-05 | 189 | 54 | 4 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 8.10e-05 | 189 | 54 | 4 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.10e-05 | 189 | 54 | 4 | 0739baad9a7da511dd3d7249f84299aee88370a1 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 8.10e-05 | 189 | 54 | 4 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 8.10e-05 | 189 | 54 | 4 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.10e-05 | 189 | 54 | 4 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-05 | 190 | 54 | 4 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | Endothelial-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 8.26e-05 | 190 | 54 | 4 | 6e83fa0eb8cabe0ffb35375f16e6bf3755ec4977 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 8.26e-05 | 190 | 54 | 4 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.26e-05 | 190 | 54 | 4 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.26e-05 | 190 | 54 | 4 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.26e-05 | 190 | 54 | 4 | 1307688255a1250fa300edf2c41f1affe31dcc98 | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.26e-05 | 190 | 54 | 4 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 8.26e-05 | 190 | 54 | 4 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.26e-05 | 190 | 54 | 4 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.26e-05 | 190 | 54 | 4 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.26e-05 | 190 | 54 | 4 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-05 | 190 | 54 | 4 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-05 | 190 | 54 | 4 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 8.43e-05 | 191 | 54 | 4 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.43e-05 | 191 | 54 | 4 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.60e-05 | 192 | 54 | 4 | fa0ef05a32c661bdd59b5a9b6f75fd647ee937f3 | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 8.60e-05 | 192 | 54 | 4 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.60e-05 | 192 | 54 | 4 | 4e63d95f75fe6eb3f817e84528883e95093c5bbd | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.60e-05 | 192 | 54 | 4 | dfb9101622f7d2f2c392e850cff07becfc8c655e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.60e-05 | 192 | 54 | 4 | d39133cf1a20af6f2970188630fc3b27a4cfc9c5 | |
| ToppCell | 18-Distal-Immune-Hematopoietic,_Natural_Killer_Cell|Distal / Age, Tissue, Lineage and Cell class | 8.60e-05 | 192 | 54 | 4 | dd47d47d0a7219771b275c4cf5f2b768424216c8 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 192 | 54 | 4 | f094ac378e635cf5820e8a8b7a0152073a51ceae | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.78e-05 | 193 | 54 | 4 | c0f0052c24b7fe9e21d2bc6c38047a8e755f87b6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.78e-05 | 193 | 54 | 4 | 54604c2c5dce2ff6f3ec7ca82b595b09b8cdafe8 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.78e-05 | 193 | 54 | 4 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 8.78e-05 | 193 | 54 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.78e-05 | 193 | 54 | 4 | 682ce63b73a7d02eef240673db67058d7507f744 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 8.95e-05 | 194 | 54 | 4 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | Endothelial-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 8.95e-05 | 194 | 54 | 4 | abea887dd472c1a0d572e690bc8914c1b94712ad | |
| Computational | Placenta genes. | 2.82e-05 | 463 | 30 | 8 | MODULE_38 | |
| Disease | neurilemmoma (is_marker_for) | 2.92e-05 | 5 | 51 | 2 | DOID:3192 (is_marker_for) | |
| Disease | brain ischemia (implicated_via_orthology) | 3.06e-05 | 35 | 51 | 3 | DOID:2316 (implicated_via_orthology) | |
| Disease | chronic kidney disease | 5.35e-05 | 235 | 51 | 5 | EFO_0003884 | |
| Disease | hypertension (implicated_via_orthology) | 7.21e-05 | 128 | 51 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | Schizophrenia | 1.27e-04 | 883 | 51 | 8 | C0036341 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 1.91e-04 | 12 | 51 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | anorexia nervosa | 2.45e-04 | 70 | 51 | 3 | MONDO_0005351 | |
| Disease | oligoclonal band measurement, multiple sclerosis | 2.63e-04 | 14 | 51 | 2 | EFO_0005206, MONDO_0005301 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 4.92e-04 | 19 | 51 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | end stage renal disease (implicated_via_orthology) | 5.46e-04 | 20 | 51 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 6.40e-04 | 97 | 51 | 3 | DOID:3083 (is_marker_for) | |
| Disease | impotence (biomarker_via_orthology) | 6.62e-04 | 22 | 51 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | uromodulin measurement | 9.27e-04 | 26 | 51 | 2 | EFO_0021778 | |
| Disease | Glioblastoma Multiforme | 9.46e-04 | 111 | 51 | 3 | C1621958 | |
| Disease | glucose tolerance test | 1.00e-03 | 27 | 51 | 2 | EFO_0004307 | |
| Disease | Intellectual Disability | 1.03e-03 | 447 | 51 | 5 | C3714756 | |
| Disease | TYPE 2 DIABETES MELLITUS | 1.08e-03 | 28 | 51 | 2 | 125853 | |
| Disease | Type 2 diabetes mellitus | 1.08e-03 | 28 | 51 | 2 | cv:C0011860 | |
| Disease | Colorectal Carcinoma | 1.29e-03 | 702 | 51 | 6 | C0009402 | |
| Disease | Colorectal Neoplasms | 1.34e-03 | 277 | 51 | 4 | C0009404 | |
| Disease | asthma (is_marker_for) | 1.36e-03 | 126 | 51 | 3 | DOID:2841 (is_marker_for) | |
| Disease | fasting blood glucose measurement | 1.53e-03 | 287 | 51 | 4 | EFO_0004465 | |
| Disease | pack-years measurement, systolic blood pressure | 1.59e-03 | 34 | 51 | 2 | EFO_0006335, EFO_0006526 | |
| Disease | Parkinsonism (biomarker_via_orthology) | 1.59e-03 | 34 | 51 | 2 | DOID:0080855 (biomarker_via_orthology) | |
| Disease | peak expiratory flow | 1.66e-03 | 498 | 51 | 5 | EFO_0009718 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SELFHFRVTVISGVT | 1021 | Q9H7T0 | |
| ALVITSIPIVFHTGF | 196 | Q8WWZ4 | |
| STPVFVHRDGVEVTE | 71 | Q9UIR0 | |
| VVRHLAVFPDTITGA | 236 | P54756 | |
| EVHAASGSLPVFVVV | 646 | P78325 | |
| VSEVFIRFFVETVGH | 1026 | P78524 | |
| TPELFASVIGVFITH | 151 | Q8NFF2 | |
| THVSELVFFIVVGVI | 191 | Q96RC9 | |
| FVIATGEVHSVREFV | 271 | O60547 | |
| VETIHISAAGFPIRV | 646 | Q96H55 | |
| VAFRVEIHTVPTIRS | 3676 | Q8NDA2 | |
| VPFHRVDTISVNGSV | 126 | Q6DKI2 | |
| VPFHRVDTISVNGSV | 126 | Q3B8N2 | |
| VPFHRVDTISVNGSV | 126 | O00182 | |
| QIVSHPFFGRVVLTA | 651 | Q9BZQ6 | |
| LVPEFGVSSSHVRVL | 86 | Q32NB8 | |
| PFLITVRQHIIFGIS | 1746 | P98164 | |
| EVIVRIIGHFFASQT | 556 | Q9Y6M1 | |
| HRFPTVAVSIGFAVR | 111 | O14732 | |
| IVRHDFSTVLTVFPI | 421 | Q9UPT5 | |
| RVVTLIEHPFVFTRE | 516 | Q8TCU5 | |
| THVVLILRGPEGFTT | 91 | P29475 | |
| FTHFNLIPVGLRVVT | 101 | Q92914 | |
| FIRPLHEGTLVFVAS | 136 | P98173 | |
| AFGVPLRTYTHEVVT | 151 | Q00526 | |
| PVGTVEFHDLVTFTR | 586 | O75054 | |
| LHFIFRILGTPTEET | 371 | Q00536 | |
| VFTAFVISNIGHIRP | 111 | P62955 | |
| IVRELHVYGSVVPVS | 471 | Q9H9T3 | |
| HFTVDPKTGVIRTAV | 216 | Q9UJ99 | |
| AFGVPVRTYTHEVVT | 151 | P24941 | |
| SPVVSVAVFHGRNFL | 2441 | Q9NYQ7 | |
| VTFPVRVFHLLGVDT | 96 | P00491 | |
| PTRRFSTIVVEEGHE | 111 | Q9BXL7 | |
| FEATSVTVIPVFHLA | 376 | Q3KNS1 | |
| FLFVVRHNPTGTVLF | 381 | P05121 | |
| VIGRFHVTLDSVLVF | 211 | Q8N807 | |
| TTVFSVGRFRVTHIE | 161 | Q8NC24 | |
| SVVHTLQTDFRGPVV | 171 | Q8WW59 | |
| TRFTKHVRIIEPGFV | 276 | P48764 | |
| LRHITVVELVGVFPT | 371 | P78539 | |
| PIAAVLITFVGHVSF | 551 | Q09428 | |
| LTTVFPGTNLVFHII | 1236 | Q8IZF2 | |
| RVTETVHTSYGPITV | 131 | A6NNL5 | |
| VTVPVATLAGRHFTE | 346 | Q96PV0 | |
| GTIPVEIHTATVIFV | 3926 | Q86WI1 | |
| RTTFHDGIVFSQRPV | 41 | Q96EH8 | |
| RSDVQIHVPTFTFRV | 56 | O75569 | |
| IHVPTFTFRVTVGDI | 61 | O75569 | |
| FISAFLVRVPSSVGH | 31 | Q9BS86 | |
| HVEVEPSVFFTRVST | 881 | Q96Q05 | |
| GHTEFVSRISVVPTQ | 186 | P57081 | |
| RVISFHVTRGPEITL | 541 | P35968 | |
| VVILVEGREFPTHRS | 36 | O95365 | |
| LKHFRVTEGSPVTFT | 951 | Q86TC9 |